"Silvamp Tb Lam" Rapid Urine Tuberculosis Test Predicts Mortality In Patients Hospitalized With Human Immunodeficiency Virus In South Africa
CLINICAL INFECTIOUS DISEASES(2020)
摘要
Reducing diagnostic delay is key toward decreasing tuberculosis-associated deaths in people living with human immunodeficiency virus. In tuberculosis patients with retrospective urine testing, the point-of-care Fujifilm SILVAMP TB LAM (FujiLAM) could have rapidly diagnosed tuberculosis in up to 89% who died. In FujiLAM negative patients, the probability of 12-week survival was 86-97%.
更多查看译文
关键词
Tuberculosis, HIV, lipoarabinomannan, point-of-care, mortality
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要